eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | c syndrome |
| Comorbidity | C0027051|myocardial infarct |
| Sentences | 21 |
| PubMedID- 20811489 | Prevalence, detection, and management of the metabolic syndrome in patients with acute myocardial infarction: role of an obesity-centric definition. |
| PubMedID- 19356813 | Obesity and the metabolic syndrome in patients with acute myocardial infarction. |
| PubMedID- 23411742 | We conclude that prevalence of metabolic syndrome in patients with premature myocardial infarction is high; high tg is the most common component of metabolic syndrome. |
| PubMedID- 22701134 | The aim of this study was to evaluate clinical impact of non-hdl-c and apob on clinical outcomes in metabolic syndrome (ms) patients with acute myocardial infarction (ami) undergoing percuatneous coronary intervetion. |
| PubMedID- 25789257 | This finding might partly explain the higher risk of development of heart failure following acute myocardial infarction in patients with metabolic syndrome. |
| PubMedID- 23715346 | The study was aimed to find out the impact of metabolic syndrome in patients with acute myocardial infarction during hospital stay. |
| PubMedID- 20890426 | We sought to determine the prevalence of metabolic syndrome (ms) in patients with acute myocardial infarction and its effect on clinical outcomes. |
| PubMedID- 22263382 | Metabolic syndrome and outcome in patients with acute myocardial infarction. |
| PubMedID- 21418805 | [antiphospholipid syndrome complicated with acute myocardial infarction: a case report]. |
| PubMedID- 22971940 | Presence of metabolic syndrome is associated with larger myocardial infarction size and complications following acute myocardial infarction. |
| PubMedID- 25563711 | Effect of angiotensin converting enzyme inhibitors on periprocedural myocardial infarction in patients with metabolic syndrome. |
| PubMedID- 21428179 | Conclusion: elevated homocysteine levels were correlated to the metabolic syndrome in patients with prior myocardial infarction. |
| PubMedID- 21487455 | Patient was diagnosed with thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, further complicated by non-st elevation myocardial infarction (nstemi), and acute pancreatitis based on the peripheral smear, thrombocytopenia, hemolytic anemia, acute renal failure, elevated cardiac biomarkers and elevated pancreatic enzymes. |
| PubMedID- 24020829 | Intra-thoracic fat volume is associated with myocardial infarction in patients with metabolic syndrome. |
| PubMedID- 21646744 | Heart failure mimicking prior myocardial infarction in a patient with idiopathic hypereosinophilic syndrome. |
| PubMedID- 22240598 | Coronary artery bypass grafting for multivessel coronary artery disease in metabolic syndrome patients with acute myocardial infarction. |
| PubMedID- 21757819 | Background: the purpose of the present study was to compare the efficacy and safety of paclitaxel-eluting stent (pes), sirolimus-eluting stent (ses), and zotarolimus-eluting stent (zes) in primary percutaneous coronary intervention (pci) for acute st-segment elevation myocardial infarction (stemi) with metabolic syndrome (ms). |
| PubMedID- 21159478 | Acute inferior myocardial infarction with nephrotic syndrome. |
| PubMedID- 20509277 | Aim: to analyze the components of metabolic syndrome from patients with cardiovascular disease (myocardial infarction). |
| PubMedID- 26309630 | The positive therapeutic effect in a patient of evans syndrome combined with acute myocardial infarction. |
| PubMedID- 23934969 | Objective: this study aimed to evaluate long-term survival according to the presence of metabolic syndrome (ms) in patients with acute myocardial infarction (ami) undergoing successful percutaneous coronary intervention (pci) with drug-eluting stents (des). |
Page: 1